NanoVelos a new approach to introducing drug - release control
NanoVelos is a biomedical start-up from the Warsaw University of Technology. Its idea was born and developed in Biomedical Engineering Laboratory. Our company concentrated on developing a unique drug delivery system made of polysaccharide nanoparticles dedicated to oncology. We are focused on creation of biodegradable, versatile anticancer drug carrier, with potential targeting properties. Carrier is formed by self-assembly with covalently attached drug, this allows controlled release depending on environment pH. The resulting system is characterized by improving targeting to tumor, safety and allowing the extension of the therapeutic window. We aim on development of innovative combinations of known anticancer drugs with polysaccharide nanoparticles. Our mission, as a company, is to reforge the idea of nanoparticles for cancer treatment into a product available for everyone. We believe that this product, due to it properties, will improve possibilities of cancer treatment and will give people a chance to avoid painful and unpleasant therapies side effects.
Sign the Declaration
The document is the work of the community of Polish startups - young and experienced entrepreneurs, investors, technology park representatives and local startup activists - united to speak with a single voice.
- N ahas just joined
- Eveline Foubertwelcome on board
- Krzysztof Pacuszkajust signed the Manifesto
- Maciej Kołtońskiis with us
- wiktoriajoined us
- Rafal Pluteckithanks for sign off
- Paweł Drygaśhas just joined
- Serhii Lebedynwelcome on board
2562 people have signed the Declaration